Chemours Co (CC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 700M 1.4B 2.1B Q3 '21: 1.7B Q4 '21: 1.6B Q1 '22: 1.8B Q2 '22: 1.9B Q3 '22: 1.8B Q4 '22: 1.3B Q1 '23: 1.5B Q2 '23: 1.6B Q3 '23: 1.5B Q4 '23: 1.4B Q1 '24: 1.4B Q2 '24: 1.6B Q3 '24: 1.5B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.6B Q3 '25: 1.5B Q4 '25: 1.3B Q1 '26: 1.4B Q2 '26: 1.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 200M 400M 600M Q3 '21: 427M Q4 '21: 393M Q1 '22: 486M Q2 '22: 497M Q3 '22: 432M Q4 '22: 202M Q1 '23: 368M Q2 '23: 410M Q3 '23: 273M Q4 '23: 251M Q1 '24: 284M Q2 '24: 308M Q3 '24: 286M Q4 '24: 265M Q1 '25: 236M Q2 '25: 278M Q3 '25: 233M Q4 '25: 156M Q1 '26: 212M Q2 '26: 286M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: 214M Q4 '21: 233M Q1 '22: 234M Q2 '22: 201M Q3 '22: 240M Q4 '22: -97M Q1 '23: 145M Q2 '23: -376M Q3 '23: 12M Q4 '23: -18M Q1 '24: 54M Q2 '24: 60M Q3 '24: -32M Q4 '24: -11M Q1 '25: -5M Q2 '25: -380M Q3 '25: 60M Q4 '25: -47M Q1 '26: -29M Q2 '26: -274M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 500M 1B 1.5B Q3 '21: 1.3B Q4 '21: 1.2B Q1 '22: 1.3B Q2 '22: 1.4B Q3 '22: 1.3B Q4 '22: 1.1B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.2B Q4 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.2B Q3 '24: 1.2B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '21: 311M Q4 '21: 208M Q1 '22: 2M Q2 '22: 291M Q3 '22: 301M Q4 '22: 161M Q1 '23: -124M Q2 '23: 67M Q3 '23: 131M Q4 '23: 482M Q1 '24: -290M Q2 '24: -620M Q3 '24: 139M Q4 '24: 138M Q1 '25: -112M Q2 '25: 93M Q3 '25: 146M Q4 '25: 137M Q1 '26: -44M Q2 '26: 158M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-750M -500M -250M 0 250M 500M 750M Q3 '21: 244M Q4 '21: 125M Q1 '22: -104M Q2 '22: 229M Q3 '22: 229M Q4 '22: 94M Q1 '23: -215M Q2 '23: 9M Q3 '23: 45M Q4 '23: 347M Q1 '24: -392M Q2 '24: -693M Q3 '24: 63M Q4 '24: 29M Q1 '25: -196M Q2 '25: 50M Q3 '25: 105M Q4 '25: 92M Q1 '26: -93M Q2 '26: 114M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q1 '20: 165.3M Q2 '20: 165.4M Q3 '20: 166.6M Q1 '21: 169.1M Q2 '21: 170.2M Q3 '21: 169M Q1 '22: 163.6M Q2 '22: 159.7M Q3 '22: 157.9M Q1 '23: 151.2M Q2 '23: 149.1M Q3 '23: 150.2M Q1 '24: 150.1M Q2 '24: 150.1M Q3 '24: 149.7M Q1 '25: 149.9M Q2 '25: 150.2M Q3 '25: 150.8M Q1 '26: 150.8M Q2 '26: 151.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '21: 2.34 Q4 '21: 3.62 Q1 '22: 4.48 Q2 '22: 5.35 Q3 '22: 5.60 Q4 '22: 3.56 Q1 '23: 3.09 Q2 '23: -0.69 Q3 '23: -2.13 Q4 '23: -1.60 Q1 '24: -2.20 Q2 '24: 0.71 Q3 '24: 0.41 Q4 '24: 0.45 Q1 '25: 0.06 Q2 '25: -2.86 Q3 '25: -2.24 Q4 '25: -2.47 Q1 '26: -2.63 Q2 '26: -1.91 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.